The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00665613

Enrollment

300

Registered

2008-04-24

Start date

2004-10-31

Completion date

2009-03-31

Last updated

2015-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Keywords

warfarin use

Brief summary

The purpose of this study is to determine if osteoporosis is an unrecognized complication of chronic anticoagulation with warfarin.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients on warfarin that have had BMD within a year

Exclusion criteria

* Patients on bisphosphates, SERMS, anticonvulsants, estrogens, androgens, calcitonin, hctz and thyroid hormone replacement

Design outcomes

Primary

Measure	Time frame	Description
Bone Density	5 to 10 years	bone density as measured by xray to assess bone strength nd risk of fracture

Countries

United States

Outcome results